From Root to Ritual
Ingredient spotlight: black seed oil — thymoquinone, the COX-2/PGD2 mechanism, and the honest evidence picture for a widely promoted natural remedy.
Black seed oil (Nigella sativa) contains thymoquinone — a compound
that inhibits COX-2 and reduces prostaglandin D2 (PGD2), an
inflammatory molecule elevated in balding scalps. A 2014 RCT found
significant improvement in hair density and thickness for telogen
effluvium patients using a topical Nigella sativa lotion vs placebo.
The honest limitation: most other evidence is small, short, or
animal-based. The evidence for AGA specifically is thin. The
anti-inflammatory mechanism is its strongest contribution. Here is
the complete picture.
Botanical Shampoo Versus Conventional Shampoo
Botanical shampoo versus conventional shampoo: compare ingredients, scalp feel, cleansing power, and how to choose a ritual that supports your hair.
Can Scalp Inflammation Cause Shedding? Yes.
Can scalp inflammation cause shedding? Learn how irritation, flakes, and stress can disrupt the hair cycle, plus gentle steps to support your daily scalp.
The $26 million hair growth injectable that started with a hairy mole — Amplifica's osteopontin discovery, the Phase 1 results, and what Eli Lilly's participation signals.
Amplifica Holdings Group closed an oversubscribed $26 million Series B
on August 12, 2026 — with Eli Lilly as a strategic investor. The
science begins with hairy moles: UCI professor Maksim Plikus discovered
that senescent pigment cells in moles produce osteopontin, a signalling
molecule that reactivates dormant hair follicle stem cells. AMP-303
— Amplifica's lead injectable candidate — completed a Phase 1 RCT
(September 2024) showing statistically significant >15% increase in
non-vellus hair count at 60 days (p<0.001) vs placebo. This is early
but genuinely interesting. Here is the complete honest picture.
How to Reduce Scalp Buildup Naturally at Home
Learn how to reduce scalp buildup naturally with gentle cleansing, botanical oils, and rituals that support a balanced, comfortable scalp and healthier hair
Post-COVID hair loss: four biological pathways, one clinical picture — and why the long COVID variant is a different problem from the acute infection one.
A 2024 multi-centre cross-sectional study of 500 female COVID-19
patients found 61.4% experienced some form of hair problem after
infection — telogen effluvium accounting for the majority. A
COVID-19 Long Haul Foundation review (May 2026) identified four
biological pathways: cytokine-driven TE, vascular injury to follicle
supply, hypoxic stress from illness severity, and immune privilege
collapse at the hair bulb. Most post-acute COVID hair loss resolves
within 6-9 months without treatment. Long COVID hair loss is a
different and more persistent problem. Here is the complete guide.
Organic Skincare Versus Natural Skincare Explained
Organic skincare versus natural skincare can look similar on a label. Learn what certification, sourcing, and formulation really reveal for your skin.
When the immune system turns on your hair: autoimmune conditions, hair loss mechanisms, and what a 2025 gut-skin discovery changes about how we investigate alopecia areata.
More than 80 autoimmune diseases exist — and hair loss features in
many of them through five distinct mechanisms: direct follicle attack
(alopecia areata), systemic inflammation-driven TE, hormone disruption
(Hashimoto's, Graves'), medication-induced TE, and scarring from
cutaneous autoimmune lesions (discoid lupus). A paper published
August 25, 2025 in JAAD (University of California, Irvine) found an
unexpected connection between microscopic colitis and alopecia areata —
suggesting the gut-skin axis is more directly relevant to AA than
previously understood. Here is the complete honest guide.
Does Poor Circulation Affect Hair? The Real Answer
Does poor circulation affect hair? Learn how blood flow, stress, nutrition, and scalp care can influence shedding, growth, and your daily ritual gently.
Frontal fibrosing alopecia: the fastest-growing scarring alopecia globally — what it is, why it's increasing, and the sunscreen hypothesis the experts are still debating.
Frontal fibrosing alopecia (FFA) is a progressive scarring alopecia
that has increased steadily in prevalence since its first description
in 1994. It primarily affects postmenopausal women — presenting as
frontal hairline recession, eyebrow loss, and facial papules. The SOFFIA
2024 international consensus statement (69 experts, 6 continents,
published JEADV July 2025) is the most authoritative current guidance.
The Spanish expert panel (January 2025) recommends avoiding organic
UV filters and benzyl salicylate in cosmetics. The JAAD April 2026
management review outlines current treatment approaches. Here is the
complete honest picture — what FFA is, how it differs from other
scarring alopecias, and the environmental trigger debate.
A Self Care Ritual for Burnout That Starts at the Root
Build a self care ritual for burnout that calms the nervous system, supports scalp and skin, and makes room for real restoration, one day at a time, gently.
Azelaic acid and hair loss: what the 2023 minoxidil comparison study found — and the honest gap between interesting evidence and proven treatment.
A 2023 study of 26 women with mild female pattern hair loss compared
5% azelaic acid to 2% topical minoxidil twice daily for six months —
both significantly improved hair density and thickness with no
statistically significant difference between them. A 2015 study found
minoxidil plus azelaic acid plus tretinoin outperformed minoxidil alone.
The honest picture: the mechanism traces to a 1988 in vitro study,
human trials are small, and azelaic acid is not a licensed hair loss
treatment. A 2026 clinical trial is now testing it specifically for
CCCA. Here is the complete evidence review.
FREE Shipping on all US Orders